Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas C Baghai

Showing results (1-10 of 85) with videos related to

Pageof 9
Sort By:
Dialogues in Clinical Neuroscience|May 14, 2008
Electroconvulsive therapy and its different indicationsThomas C Baghai, Hans-Jürgen Möller
Core Evidence|August 10, 2010
Agomelatine: The evidence for its place in the treatment of depressionDaniela Eser, Thomas C Baghai, Hans-Jürgen Möller
International Clinical Psychopharmacology|January 19, 2008
Evidence of agomelatine's antidepressant efficacy: the key pointsDaniela Eser, Thomas C Baghai, Hans-Jürgen Möller
Current Pharmaceutical Design|February 14, 2006
Recent progress in pharmacological and non-pharmacological treatment options of major depressionThomas C Baghai, Hans-Jürgen Möller, Rainer Rupprecht
Dialogues in Clinical Neuroscience|November 5, 2008
Effects of different antidepressant treatments on the core of depressionThomas C Baghai, Daniela Eser, Hans-Jürgen Möller
Expert Review of Neurotherapeutics|July 11, 2009
Hypothalamic-pituitary-adrenocortical system dysregulation and new treatment strategies in depressionCornelius Schüle, Thomas C Baghai, Daniela Eser, et al.
Zeitschrift Fur Kinder- Und Jugendpsychiatrie Und Psychotherapie|February 8, 2023
[Depressive Disorders in Adolescence: Current State of Studies Concerning the Microbiota-Gut-Brain Axis]Stephanie Kandsperger, Romuald Brunner, Rainer Rupprecht, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|October 31, 2006
Drug treatment of depression in the 2000s: An overview of achievements in the last 10 years and future possibilitiesThomas C Baghai, Hans-Peter Volz, Hans-Jürgen Möller
Frontiers in Psychiatry|September 8, 2017
"I Am I and My Bacterial Circumstances": Linking Gut Microbiome, Neurodevelopment, and DepressionJuan M Lima-Ojeda, Rainer Rupprecht, Thomas C Baghai
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|February 4, 2017
Neurobiology of depression: A neurodevelopmental approachJuan M Lima-Ojeda, Rainer Rupprecht, Thomas C Baghai
Pageof 9

Showing results (1-10 of 85) with videos related to

Sort By:
Pageof 9
Dialogues in Clinical Neuroscience|May 14, 2008
Electroconvulsive therapy and its different indicationsThomas C Baghai, Hans-Jürgen Möller
Core Evidence|August 10, 2010
Agomelatine: The evidence for its place in the treatment of depressionDaniela Eser, Thomas C Baghai, Hans-Jürgen Möller
International Clinical Psychopharmacology|January 19, 2008
Evidence of agomelatine's antidepressant efficacy: the key pointsDaniela Eser, Thomas C Baghai, Hans-Jürgen Möller
Current Pharmaceutical Design|February 14, 2006
Recent progress in pharmacological and non-pharmacological treatment options of major depressionThomas C Baghai, Hans-Jürgen Möller, Rainer Rupprecht
Dialogues in Clinical Neuroscience|November 5, 2008
Effects of different antidepressant treatments on the core of depressionThomas C Baghai, Daniela Eser, Hans-Jürgen Möller
Expert Review of Neurotherapeutics|July 11, 2009
Hypothalamic-pituitary-adrenocortical system dysregulation and new treatment strategies in depressionCornelius Schüle, Thomas C Baghai, Daniela Eser, et al.
Zeitschrift Fur Kinder- Und Jugendpsychiatrie Und Psychotherapie|February 8, 2023
[Depressive Disorders in Adolescence: Current State of Studies Concerning the Microbiota-Gut-Brain Axis]Stephanie Kandsperger, Romuald Brunner, Rainer Rupprecht, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|October 31, 2006
Drug treatment of depression in the 2000s: An overview of achievements in the last 10 years and future possibilitiesThomas C Baghai, Hans-Peter Volz, Hans-Jürgen Möller
Frontiers in Psychiatry|September 8, 2017
"I Am I and My Bacterial Circumstances": Linking Gut Microbiome, Neurodevelopment, and DepressionJuan M Lima-Ojeda, Rainer Rupprecht, Thomas C Baghai
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|February 4, 2017
Neurobiology of depression: A neurodevelopmental approachJuan M Lima-Ojeda, Rainer Rupprecht, Thomas C Baghai
Pageof 9